Evidence map›Paper›PMID 40607282›Full record

ReviewAnnals of gastroenterological surgery2025

Advantages of subtotal gastrectomy for upper third gastric cancer: A systematic review and meta-analysis.

Yuichiro Miki, Tsubasa Bito, Yasufumi Koterazawa, Shingo Kanaji, Hisashi Shinohara

Abstract readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuichiro MikiDepartment of Gastroenterological Surgery Osaka Metropolitan University Graduate School of Medicine Osaka Japan.ORCID https://orcid.org/0000-0003-0116-0922
Tsubasa BitoDepartment of Medical Statistics Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Yasufumi KoterazawaDepartment of Gastroenterological Surgery Kobe University Graduate School of Medicine Hyogo Japan.
Shingo KanajiDepartment of Gastroenterological Surgery Kobe University Graduate School of Medicine Hyogo Japan.ORCID https://orcid.org/0000-0002-8698-8923
Hisashi ShinoharaDepartment of Gastroenterological Surgery Hyogo Medical University Hyogo Japan.ORCID https://orcid.org/0000-0001-8931-1902

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Distal gastrectomy with very small remnant stomach (subtotal gastrectomy, STG) is sometimes performed for upper third gastric cancer, instead of total gastrectomy (TG). However, the advantages of STG over TG remain fully unknown, in terms of survival outcomes, complication rates, nutritional status, and quality of life. Therefore, a systematic review was performed in accordance with the preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension statement for reporting systematic reviews. Meta-analyses were performed regarding operation time, complication rates, body weight changes, and reflux esophagitis by using R software. Operation time was significantly shorter in STG than in TG (Mean difference: -20.79 [95% CI: -35.59 to -5.99]). We cannot conclude whether STG is better than TG in terms of survival because of inconsistency among reports. The total complication rates (≧ grade2 and 3) are significantly lower in STG than TG. Reflux esophagitis was lower in STG than in TG (0% vs. 7.7%), although the difference was not significant probably because of small sample size. Body weight change compared with preoperative value was significantly lower after STG than TG both at 6 and 12 months after the operation (6 months: mean difference -5.31% [95% CI: -6.95 to -3.67], 12 months: mean difference -6.13 [95% CI: -8.20 to -4.06]). We revealed that STG has its advantage on shorter operation time, less complication rates, and lower body weight loss by meta-analysis. Although there are some controversies, STG can be an ideal option for patients with gastric cancer of upper third stomach.

Indexed as

meta‐analysissubtotal gastrectomyupper third gastric cancer

Identifiers

PMID40607282
PMCPMC12211096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.